Moneycontrol
HomeNewsBusinessAnnouncementsLupin receives approval for Acotiamide tablets to treat functional dyspepsia
Trending Topics
Sensex Live
PhonePe IPO
BMW Ventures IPO
Epack Prefab Technologies IPO GMP
Jain Resource Recycling IPO

Lupin receives approval for Acotiamide tablets to treat functional dyspepsia

Lupin has received approval for Acotiamide 100 mg Tablets from the Central Drugs Standard Control Organisation (CDSCO).

August 22, 2016 / 13:19 IST
Story continues below Advertisement
Remove Ad

Lupin Ltd has informed BSE regarding a Press Release dated August 22, 2016 titled "Lupin Receives Approval for Acotiamide Tablets to Treat Functional Dyspepsia".Source : BSE

Read all announcements in Lupin

Read More

first published: Aug 22, 2016 01:19 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Follow Us On: Facebook twitter instagram linkedin telegram youtube
Trending Topics
Sensex Today PhonePe IPO Shashi Tharoor IPO GMP Live Tax Audit Donald Trump Kolkata Rain Congress CWC Meet Gold Price Volvo EX30 Price in India
News
Business Markets Stocks India News City News Economy Mutual Funds Personal Finance IPO News Startups
Markets
Home Currencies Commodities Pre-Market IPO Global Market Bonds
Personal Finance
Home Loans up to 50 Lakhs Credit Cards Lifetime Free Finance Tracker New Fixed Deposits Fixed Deposit Comparison Fixed Income
Mutual Funds
Home MC 30 Top Ranked Funds ETFs Mutual Fund Screener
Tools
Income Tax Calculator EMI Calculator Retirement Planning Gratuity Calculator Petrol Price in India Diesel Price in India IFSC Code
Community
Stock Markets
Network 18 Sites
News18 Firstpost CNBC TV18 News18 Hindi Cricketnext Overdrive
Quick Links
About Us Contact Us Advisory Alert Advertise with Us Disclaimer Privacy Policy Cookie Policy Terms & Conditions Financial Terms (Glossary) Sitemap Investors
Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.